Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 610

1.

Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.

Bloom GS.

JAMA Neurol. 2014 Apr;71(4):505-8. doi: 10.1001/jamaneurol.2013.5847. Review.

PMID:
24493463
2.

[Alzheimer disease: cellular and molecular aspects].

Octave JN.

Bull Mem Acad R Med Belg. 2005;160(10-12):445-9; discussion 450-1. French.

PMID:
16768248
3.

[The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"].

Tamaoka A.

Rinsho Byori. 2013 Nov;61(11):1060-9. Review. Japanese.

PMID:
24450113
4.

Alzheimer's disease.

De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV.

Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Review.

PMID:
23225010
5.

Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice.

Oddo S, Caccamo A, Cheng D, Jouleh B, Torp R, LaFerla FM.

J Neurochem. 2007 Aug;102(4):1053-63. Epub 2007 Apr 30.

6.

[Involvement of beta-amyloid in the etiology of Alzheimer's disease].

Tomiyama T.

Brain Nerve. 2010 Jul;62(7):691-9. Review. Japanese.

PMID:
20675873
7.

Intraneuronal Aβ accumulation, amyloid plaques, and synapse pathology in Alzheimer's disease.

Capetillo-Zarate E, Gracia L, Tampellini D, Gouras GK.

Neurodegener Dis. 2012;10(1-4):56-9. doi: 10.1159/000334762. Epub 2012 Jan 21.

PMID:
22269167
8.

Protein aggregation in Alzheimer's disease: Aβ and τ and their potential roles in the pathogenesis of AD.

Thal DR, Fändrich M.

Acta Neuropathol. 2015 Feb;129(2):163-5. doi: 10.1007/s00401-015-1387-2. No abstract available.

PMID:
25600324
9.

Alzheimer's disease and amyloid: culprit or coincidence?

Skaper SD.

Int Rev Neurobiol. 2012;102:277-316. doi: 10.1016/B978-0-12-386986-9.00011-9. Review.

PMID:
22748834
10.

Viewpoint: Crosstalks between neurofibrillary tangles and amyloid plaque formation.

Luan K, Rosales JL, Lee KY.

Ageing Res Rev. 2013 Jan;12(1):174-81. doi: 10.1016/j.arr.2012.06.002. Epub 2012 Jun 19. Review.

PMID:
22728532
11.
12.

Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease.

Takahashi RH, Nagao T, Gouras GK.

Pathol Int. 2017 Apr;67(4):185-193. doi: 10.1111/pin.12520. Epub 2017 Mar 5. Review.

PMID:
28261941
13.

A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model.

Hurtado DE, Molina-Porcel L, Iba M, Aboagye AK, Paul SM, Trojanowski JQ, Lee VM.

Am J Pathol. 2010 Oct;177(4):1977-88. doi: 10.2353/ajpath.2010.100346. Epub 2010 Aug 27.

14.

Role of PrP(C) Expression in Tau Protein Levels and Phosphorylation in Alzheimer's Disease Evolution.

Vergara C, Ordóñez-Gutiérrez L, Wandosell F, Ferrer I, del Río JA, Gavín R.

Mol Neurobiol. 2015;51(3):1206-20. doi: 10.1007/s12035-014-8793-7. Epub 2014 Jun 26.

PMID:
24965601
15.

Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.

Iqbal K, Alonso AC, Gong CX, Khatoon S, Pei JJ, Wang JZ, Grundke-Iqbal I.

J Neural Transm Suppl. 1998;53:169-80. Review.

PMID:
9700655
16.

Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport.

Sherman MA, LaCroix M, Amar F, Larson ME, Forster C, Aguzzi A, Bennett DA, Ramsden M, Lesné SE.

J Neurosci. 2016 Sep 14;36(37):9647-58. doi: 10.1523/JNEUROSCI.1899-16.2016.

17.

Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid.

Culvenor JG, McLean CA, Cutt S, Campbell BC, Maher F, Jäkälä P, Hartmann T, Beyreuther K, Masters CL, Li QX.

Am J Pathol. 1999 Oct;155(4):1173-81.

18.

Pharmacologic reversal of neurogenic and neuroplastic abnormalities and cognitive impairments without affecting Aβ and tau pathologies in 3xTg-AD mice.

Blanchard J, Wanka L, Tung YC, Cárdenas-Aguayo Mdel C, LaFerla FM, Iqbal K, Grundke-Iqbal I.

Acta Neuropathol. 2010 Nov;120(5):605-21. doi: 10.1007/s00401-010-0734-6. Epub 2010 Aug 10.

PMID:
20697724
19.

A lifespan observation of a novel mouse model: in vivo evidence supports aβ oligomer hypothesis.

Zhang Y, Lu L, Jia J, Jia L, Geula C, Pei J, Xu Z, Qin W, Liu R, Li D, Pan N.

PLoS One. 2014 Jan 21;9(1):e85885. doi: 10.1371/journal.pone.0085885. eCollection 2014.

20.

Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease.

Gamblin TC, Chen F, Zambrano A, Abraha A, Lagalwar S, Guillozet AL, Lu M, Fu Y, Garcia-Sierra F, LaPointe N, Miller R, Berry RW, Binder LI, Cryns VL.

Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):10032-7. Epub 2003 Jul 29.

Supplemental Content

Support Center